ArticleACS omega2026
Protective Effects of Lithium Borate on Acute Lung Injury Induced by Intestinal Ischemia/Reperfusion in Rats.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study investigated the protective effects of lithium borate (LTB) against lung injury secondary to intestinal ischemia/reperfusion (I/R) in rats. Twenty-four male Wistar rats were allocated to four groups: control, I/R, LTB, and I/R+LTB. Intestinal ischemia was induced by superior mesenteric artery occlusion for 45 min, followed by 3 h of reperfusion. The LTB group received 15 mg/kg oral LTB for 5 days; the I/R+LTB group underwent I/R following the same LTB protocol. At the end of the experiment, lung tissue samples were taken from the rats and subjected to biochemical, histopathological, and immunohistochemical analyses. Biochemical results showed an increase in superoxide dismutase (SOD) activity, a reduction in catalase (CAT) and glutathione peroxidase (GSH-Px) activities, a reduction in glutathione (GSH) levels, and an increase in malondialdehyde (MDA) levels in the I/R group. LTB treatment reduced oxidative stress by bringing these parameters to values close to those of the control group. Histopathological examination revealed edema, hemorrhage, thickening of the interalveolar septa, and marked inflammatory cell infiltration in the I/R group, which were substantially attenuated in the I/R+LTB group. Immunohistochemical analyses showed increased Bcl-2 and caspase-3 expression in the I/R group, whereas LTB treatment was associated with reduced caspase-3 expression and modulation of Bcl-2 immunoreactivity. In conclusion, LTB attenuates oxidative stress, reduces histopathological lung damage, and suppresses apoptosis following intestinal I/R injury, suggesting its potential protective role against remote lung injury.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.